ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 1,602.00
-36.00 (-2.20%)
Oct 12, 2026, 3:30 PM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 47.49 billion as of October 12, 2026. It is the 32,802nd most valuable company in the world and the 1,872nd biggest in South Korea. Its market cap has decreased by 28.35% in one year.
Market Cap
47.49B
Enterprise Value
n/a
Revenue
59.09B
Global Rank
Country Rank
#1,872 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 47.49B, an increase of 52.20%. That is a compound annual growth rate of 1.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 47.49B | -33.36% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 162.00B |
| Genexine | 132.12B |
| MedPacto | 102.31B |
| Vaxcell-Bio Therapeutics | 101.05B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 71.63B |
| Amicogen | 69.47B |
| ENCell | 64.74B |